- Mortgage Demand Boosted by Refis as Rates Drop
- Procter & Gamble Profit Falls, Hurt by Weak Sales
- Marsh & McLennan Posts Second-Quarter Loss
- Citi Plans to Sell 20 Consumer Finance Businesses
- What's the Trade on Market Barometer Cisco?
- US to Sell More Inflation-Protected Bonds: Report
- Lloyds' Bad Debts Hit $22 Billion, Posts Loss
- Scandinavians Make Best Husbands, Survey Says
- Buffett Accepts Resignation of NetJets Creator
- Pros Say: Forecasts Show Risk is Lower
- Warren Buffett 'Reluctantly' Accepts Decision By NetJets Creator To Step Down
- How to Cash in on Copper: Stock Picker
- Pullback is Coming — So Wait to Buy: Strategists
- Is It Worth Guzzling That 'Clunker' Cash?
- A Few Good Tweets (Updated)
- Discovery Doubles Earnings From Continuing Operations
- Animalistic Behavior Against Novartis
- 4 Internet Stocks on the Rise
- Transportation chief: ‘Clunkers’ is huge success
- Garmin 2Q results top estimates; shares climb
- Spike in suicide calls due to economy
- Baker Hughes 2Q profit tumbles as demand sinks
- P&G's fourth-quarter profit and sales decline
- Dean Foods 2Q profit rises; co. raises '09 outlook
- Reps. Peterson, Walz defend climate-change votes
- Kansas and Colorado end Arkansas River case
- Mo. court allows suit over TV listings to proceed
WellPoint reports profit slump on investment loss
INDIANAPOLIS - Health insurer WellPoint Inc. says its profit fell 7.6 percent in the second quarter as it felt the effect of investment losses.
The Indianapolis company says it earned $693.5 million, or $1.43 per share, compared with $750.5 million, or $1.44 per share, in the same quarter last year.
Revenue fell slightly to $15.41 billion.
Thomson Reuters says analysts expected expect, on average, earnings of $1.43 per share on $15.41 billion in revenue.
Medical enrollment fell by 1.1 million members, mainly due to rising unemployment.
WellPoint now expects a full-year profit of $5.06 to $5.12 per share, down from a previous outlook of $5.14 to $5.20 per share.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.



